PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31004883-10	2019	Moreover, abnormal GSK-3beta/beta-catenin signaling in HepG2 cells was remarkably suppressed by PAB treatment.	pseudolaric acid B	96-99	glycogen synthase kinase 3 beta	Homo sapiens	19-28	
31004883-12	2019	CONCLUSION: Taken together, our results suggest that PAB exerts anti-cancer activity in HCC cells through inhibition of STAT3, ERK1/2, Akt, and GSK-3beta/beta-catenin carcinogenic signaling pathways, and may be used as a phytomedicine in the treatment of HCC.	pseudolaric acid B	53-56	glycogen synthase kinase 3 beta	Homo sapiens	144-153	
28422767-0	2017	Pseudolaric acid B induces endometrial cancer Ishikawa cell apoptosis and inhibits metastasis through AKT-GSK-3beta and ERK1/2 signaling pathways.	pseudolaric acid B	0-18	glycogen synthase kinase 3 beta	Homo sapiens	106-115	
28422767-4	2017	We found that PAB inhibited Ishikawa cell proliferation, and induced cell apoptosis and G2/M phase arrest through a mechanism involving AKT-GSK-3beta and ERK1/2 signaling pathways.	pseudolaric acid B	14-17	glycogen synthase kinase 3 beta	Homo sapiens	140-149